Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis

Clinical trial NCT05240859 · UNKNOWN

Trial details

NCT number: NCT05240859
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Rheumatoid Arthritis

Start date: 2022-02-22
Primary completion: 2024-02-28
Enrollment: 1600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.